|Day's Range||181.06 - 182.86|
|52 Week Range||139.07 - 182.86|
|PE Ratio (TTM)||33.23|
|Earnings Date||Jul 26, 2017|
|Dividend & Yield||0.60 (0.33%)|
|1y Target Est||194.13|
Lower TAVR sales due to recall of Lotus valves within the European and other key markets is likely to mar Boston Scientific's (BSX) top-line performance in Q2.
WALTHAM, Mass. , July 18, 2017 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO) (" Thermo Fisher ") announced today that it has priced an offering of €2.6 billion aggregate principal ...
Strong focus on product launch and emerging market expansion should drive Thermo Fisher (TMO) toward an earnings beat in Q2.